[go: up one dir, main page]

WO2009034559A3 - Cosmetic process for aesthetic and/or repairing treatment of the skin - Google Patents

Cosmetic process for aesthetic and/or repairing treatment of the skin Download PDF

Info

Publication number
WO2009034559A3
WO2009034559A3 PCT/IB2008/053728 IB2008053728W WO2009034559A3 WO 2009034559 A3 WO2009034559 A3 WO 2009034559A3 IB 2008053728 W IB2008053728 W IB 2008053728W WO 2009034559 A3 WO2009034559 A3 WO 2009034559A3
Authority
WO
WIPO (PCT)
Prior art keywords
aesthetic
skin
cosmetic process
repairing treatment
individual
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IB2008/053728
Other languages
French (fr)
Other versions
WO2009034559A2 (en
Inventor
Bris Benedicte Le
Pascale Pelletier
Corinne Granger
Catherine Marion
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LOreal SA filed Critical LOreal SA
Publication of WO2009034559A2 publication Critical patent/WO2009034559A2/en
Publication of WO2009034559A3 publication Critical patent/WO2009034559A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/602—Glycosides, e.g. rutin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/91—Injection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention relates to a cosmetic process for aesthetic and/or repairing treatment of the skin of an individual, comprising at least one step of administering, to the said individual, according to a mesotherapy technique, a sterile fluid composition containing, in a physiologically acceptable medium, at least one C-glycoside derivative.
PCT/IB2008/053728 2007-09-14 2008-09-15 Cosmetic process for aesthetic and/or repairing treatment of the skin Ceased WO2009034559A2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FR0757558A FR2920968B1 (en) 2007-09-14 2007-09-14 COSMETIC PROCESS FOR AESTHETIC TREATMENT AND / OR REPAIR OF SKIN
FR0757558 2007-09-14
US97680107P 2007-10-02 2007-10-02
US60/976,801 2007-10-02

Publications (2)

Publication Number Publication Date
WO2009034559A2 WO2009034559A2 (en) 2009-03-19
WO2009034559A3 true WO2009034559A3 (en) 2009-06-25

Family

ID=39410184

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2008/053728 Ceased WO2009034559A2 (en) 2007-09-14 2008-09-15 Cosmetic process for aesthetic and/or repairing treatment of the skin

Country Status (2)

Country Link
FR (1) FR2920968B1 (en)
WO (1) WO2009034559A2 (en)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2861734B1 (en) 2003-04-10 2006-04-14 Corneal Ind CROSSLINKING OF LOW AND HIGH MOLECULAR MASS POLYSACCHARIDES; PREPARATION OF INJECTABLE SINGLE PHASE HYDROGELS; POLYSACCHARIDES AND HYDROGELS OBTAINED
FR2902999B1 (en) 2006-07-03 2012-09-28 Oreal USE OF C-GLYCOSIDE DERIVATIVES AS PRODESQUAMANT INGREDIENTS
CA2703109C (en) 2007-11-16 2017-07-18 Vicept Therapeutics, Inc. Compositions and methods for treating purpura
US8394782B2 (en) 2007-11-30 2013-03-12 Allergan, Inc. Polysaccharide gel formulation having increased longevity
US8450475B2 (en) 2008-08-04 2013-05-28 Allergan, Inc. Hyaluronic acid-based gels including lidocaine
AU2009288118B2 (en) 2008-09-02 2014-12-11 Allergan, Inc. Threads of hyaluronic acid and/or derivatives thereof, methods of making thereof and uses thereof
FR2940610B1 (en) 2008-12-30 2011-05-06 Oreal ASSOCIATION OF MONOSACCHARIDES WITH C-GLYCOSIDE DERIVATIVES AND ITS USE IN COSMETICS
US20110172180A1 (en) 2010-01-13 2011-07-14 Allergan Industrie. Sas Heat stable hyaluronic acid compositions for dermatological use
US9114188B2 (en) 2010-01-13 2015-08-25 Allergan, Industrie, S.A.S. Stable hydrogel compositions including additives
FR2957254B1 (en) 2010-03-12 2016-10-14 Allergan Ind Sas FLUID COMPOSITIONS FOR IMPROVING SKIN CONDITIONS
CA2794254C (en) 2010-03-22 2018-09-04 Allergan, Inc. Polysaccharide and protein-polysaccharide cross-linked hydrogels for soft tissue augmentation
US8889123B2 (en) 2010-08-19 2014-11-18 Allergan, Inc. Compositions and soft tissue replacement methods
US8883139B2 (en) 2010-08-19 2014-11-11 Allergan Inc. Compositions and soft tissue replacement methods
US9005605B2 (en) 2010-08-19 2015-04-14 Allergan, Inc. Compositions and soft tissue replacement methods
US9393263B2 (en) 2011-06-03 2016-07-19 Allergan, Inc. Dermal filler compositions including antioxidants
US20130096081A1 (en) 2011-06-03 2013-04-18 Allergan, Inc. Dermal filler compositions
KR102312056B1 (en) 2011-06-03 2021-10-12 알러간 인더스트리 에스에이에스 Dermal filler compositions including antioxidants
US9408797B2 (en) 2011-06-03 2016-08-09 Allergan, Inc. Dermal filler compositions for fine line treatment
US9662422B2 (en) 2011-09-06 2017-05-30 Allergan, Inc. Crosslinked hyaluronic acid-collagen gels for improving tissue graft viability and soft tissue augmentation
US20130244943A1 (en) 2011-09-06 2013-09-19 Allergan, Inc. Hyaluronic acid-collagen matrices for dermal filling and volumizing applications
CA2850384C (en) * 2011-09-30 2023-08-15 The University Of Sydney In vivo synthesis of elastic fiber
US9688741B2 (en) 2012-10-23 2017-06-27 Elastagen Pty Ltd Elastic hydrogel
ES2702602T3 (en) 2012-12-10 2019-03-04 Allergan Pharmaceuticals Int Ltd Manufacture of scalable three-dimensional elastic constructions
KR102488446B1 (en) 2013-08-13 2023-01-13 앨러간 파마슈티컬스 인터내셔널 리미티드 Regeneration of damaged tissue
ES2761558T3 (en) 2014-09-30 2020-05-20 Allergan Ind Sas Stable hydrogel compositions including additives
WO2016128783A1 (en) 2015-02-09 2016-08-18 Allergan Industrie Sas Compositions and methods for improving skin appearance
BR112017017346B1 (en) 2015-02-13 2021-09-08 Allergan Industrie, Sas STERILE COMPOSITION, SUBDERMICAL OR SUPRAPERIOSTEAL IMPLANTABLE IN THE CHIN AREA, JAW OR NOSE LINE, USES AN EFFECTIVE AMOUNT OF HYALURONIC ACID (HA) RETICULATED WITH BDDE AND KIT
AU2019267711B2 (en) 2018-05-09 2025-04-17 The Johns Hopkins University Nanofiber-hydrogel composites for cell and tissue delivery
CA3099733A1 (en) 2018-05-09 2019-11-14 The Johns Hopkins University Nanofiber-hydrogel composites for enhanced soft tissue replacement and regeneration

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002051828A2 (en) * 2000-12-22 2002-07-04 L'oreal Novel c-glycoside derivatives and use thereof
FR2869317A1 (en) * 2004-04-23 2005-10-28 Oreal NOVEL C-GLYCOSIDE DERIVATIVES AND COSMETIC USES

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002051828A2 (en) * 2000-12-22 2002-07-04 L'oreal Novel c-glycoside derivatives and use thereof
FR2869317A1 (en) * 2004-04-23 2005-10-28 Oreal NOVEL C-GLYCOSIDE DERIVATIVES AND COSMETIC USES

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
ANDRE P: "Hyaluronic acid and its use as a ''rejuvenation'' agent in cosmetic dermatology", SEMINARS IN CUTANEOUS MEDICINE AND SURGERY, W.B. SAUNDERS, PHILADELPHIA, US, vol. 23, no. 4, 1 December 2004 (2004-12-01), pages 218 - 222, XP004700714, ISSN: 1085-5629 *
DATABASE EMBASE [online] ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL; July 2006 (2006-07-01), SINGH K: "Non surgical facial rejuvenation", XP002481857, Database accession no. EMB-2007217856 *
JOURNAL INTERNATIONAL MEDICAL SCIENCES ACADEMY 200607 IN, vol. 19, no. 3, July 2006 (2006-07-01), pages 158 - 164, ISSN: 0971-071X *

Also Published As

Publication number Publication date
FR2920968B1 (en) 2009-11-13
FR2920968A1 (en) 2009-03-20
WO2009034559A2 (en) 2009-03-19

Similar Documents

Publication Publication Date Title
WO2009034559A3 (en) Cosmetic process for aesthetic and/or repairing treatment of the skin
WO2009040420A3 (en) Use of a monoterpene to increase tissue repair
WO2009074735A3 (en) Use of a novel natural agent in cosmetic compositions
WO2007128817A3 (en) Insulin derivative
WO2007089454A3 (en) Methods for enhancing skin treatments
WO2008139122A3 (en) Pharmaceutical or cosmetic preparations for topical and/or parenteral application, preparation methods thereof and use of same
WO2009101503A3 (en) Use of natural active substances in cosmetic or therapeutic compositions
WO2006087759A3 (en) Pharmaceutical composition comprising curcumin and resveratrol and uses thereof in medical field
WO2007002572A3 (en) Nattokinase for reducing whole blood viscosity
WO2008151749A3 (en) Activatable diagnostic and therapeutic compound
WO2009125925A3 (en) Growth factor-mimicking peptides and uses thereof
WO2013034855A3 (en) Combination of carrageenan and c-glycoside and uses thereof
WO2015031971A8 (en) A composition comprising guaçatonga extract and aroeira extract/ use thereof and a method for preventing and/or treating signals caused by skin aging
WO2008107092A3 (en) Use of derivatives of 4-hydroxyphenoxy acetic acid
WO2008139123A3 (en) Pharmaceutical or cosmetic preparations for topical and/or parenteral application, preparation methods thereof and use of same
WO2008062467A3 (en) Cultured melanocytes on biopolymers
WO2008004165A3 (en) Use of c-glycoside derivatives as pro-desquamating active agents
MX2009003060A (en) Emulsion.
WO2011073438A3 (en) Cosmetic method for treating body odours using a bacteriocin based composition
WO2009090085A8 (en) Abnormal intraocular pressure treatment
WO2014049561A3 (en) Oral composition for reinforcing skin tolerance following topical administration of a retinoid compound
WO2009106555A3 (en) Sterilized sucralfate gel
MX2009012712A (en) Novel 4-phenyl-imidazole-2-thiones used as tyrosinase inhibitors, method for preparing same and use thereof in human medicine and cosmetology.
WO2008034989A3 (en) Use of quinoa extract as cosmetic and pharmaceutic slimming agent and/or as an agent preventing the formation of new fats in the human body
MX2009012714A (en) Novel 4-heteroaryl-imidazole-2-thiones used as tyrosinase inhibitors, method for preparing same and use thereof in human medicine and cosmetology.

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08807658

Country of ref document: EP

Kind code of ref document: A2

122 Ep: pct application non-entry in european phase

Ref document number: 08807658

Country of ref document: EP

Kind code of ref document: A2